As cancer cells rely on lactate dehydrogenase and cytosolic malate dehydrogenase 1 in regenerating cytosolic NAD+ [64], a downregulation of SLC25A13 does not compromise HCC cell survival. Here, SLC25A13 is linked to cancer.